USPTO serial 87899061
NTXBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 21, 2020
- Examiner
- DONEGAN, DANIEL P
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with NTXBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Santa Fe, NM, US
Santa Fe, NM, US
Santa Fe, NM, US
Rio Rancho, NM, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David Kerr
David Kerr BERG HILL GREENLEAF AND RUSCITTI, LLP1712 PEARLBOULDER, CO 80302United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules | ACTIVE | Jul 28, 2017 |
| 042 | Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data | ACTIVE | Jul 28, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NtxBio, LLC
- Other trademarks owned by NtxBio, LLC
- Other trademarks owned by NtxBio, LLC
- Other trademarks owned by NATURE'S TOOLBOX, INC.
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named NTXBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 3, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 3, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 3, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 21, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 21, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 23, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Dec 9, 2020 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 21, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 16, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 10, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 10, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 3, 2019 | IUAF | USE AMENDMENT FILED | — |
| Dec 3, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 4, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 9, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 27, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 26, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 21, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 21, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 20, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| May 8, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2018 | NWAP | NEW APPLICATION ENTERED | — |